S100B and neoplasm: In the validation cohort-A, there was a trend for a positive association between S100B plasma levels and tumor volume in male VS patients (Fig. 4I), which approached the criterion for statistical significance after correction for multiple comparisons by controlling the false discovery rate (FDR) to 0.10 (P = 0.025, critical value: 0.023 in male VS patients).